The Journal of Urology
Volume 178, Issue 3, Supplement , Pages S5-S8, September 2007

Innovations and Challenges in Prostate Cancer: Summary Statement for the 6th Cambridge Conference

  • Philip W. Kantoff

      Affiliations

    • Lank Center for Genitourinary Oncology, Boston, Massachusetts
    • ,
  • Tomasz M. Beer

      Affiliations

    • Division of Hematology and Medical Oncology and Oregon Health and Science University Cancer Institute, Oregon Health and Science University, Portland, Oregon
    • ,
  • Anthony V. D’Amico

      Affiliations

    • Dana-Farber Cancer Institute, Boston, Massachusetts
    • Department of Radiation Oncology, Brigham and Women’s Hospital, Boston, Massachusetts
    • ,
  • Robert S. DiPaola

      Affiliations

    • Cancer Institute of New Jersey, New Brunswick, New Jersey
    • ,
  • Mario A. Eisenberger

      Affiliations

    • Departments of Oncology and Urology, Johns Hopkins University, Baltimore, Maryland
    • ,
  • Maha H.A. Hussain

      Affiliations

    • Department of Internal Medicine (Division of Hematology and Oncology), University of Michigan, Ann Arbor, Michigan
    • ,
  • William Kevin Kelly

      Affiliations

    • Department of Medical Oncology, Yale University, New Haven, Connecticut
    • ,
  • Paul Mathew

      Affiliations

    • M. D. Anderson Cancer Center, Houston
    • ,
  • Michael J. Morris

      Affiliations

    • Genitourinary Oncology Service, Department of Medicine and Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Department of Medicine, Joan and Sanford E. Weill College of Medicine of Cornell University, New York, New York
    • ,
  • Charles J. Ryan

      Affiliations

    • Department of Medicine, University of California-San Francisco, San Francisco, California
    • University of California-San Francisco Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California
    • ,
  • Howard M. Sandler

      Affiliations

    • Department of Radiation Oncology and Urology, University of Michigan, Ann Arbor, Michigan
    • ,
  • Ian M. Thompson

      Affiliations

    • Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
    • ,
  • Peter R. Carroll

      Affiliations

    • Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, University of California-San Francisco, San Francisco, California

published online 18 July 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0022-5347(07)00825-7

doi:10.1016/j.juro.2007.03.137

The Journal of Urology
Volume 178, Issue 3, Supplement , Pages S5-S8, September 2007

Article Tools